Alvotech SA

21 de ago. de 2026, 19:51 UTC

Alvotech SA has signed a licensing agreement with Lotus Pharmaceutical for two biosimilars, potentially generating $150 million in payments, as shares trade higher.

20 de ago. de 2026, 20:02 UTC

Alvotech reaffirms 2026 revenue guidance amid Q2 revenue decline.

19 de ago. de 2026, 23:01 UTC

Alvotech SA reaffirmed its 2026 sales guidance of $650 million to $700 million, boosting investor sentiment and driving shares higher in after-market trading.

18 de ago. de 2026, 19:16 UTC

Alvotech SA shares are higher today, maintaining a cumulative gain since Monday. The stock is above its 20-day moving average and near its one-month high.

17 de ago. de 2026, 21:02 UTC

Alvotech SA shares rose during after-market hours, reaching a high of 2.84%. The price is above its 20-day moving average and near a one-month high.

14 de ago. de 2026, 19:56 UTC

Alvotech SA shares are trading roughly flat amid broader market sentiment influenced by a decline in U.S. retail sales for July.

13 de ago. de 2026, 20:06 UTC

Alvotech SA shares are higher during Thursday's session, continuing an upward trend since Wednesday's close, trading above its 20-day moving average.

12 de ago. de 2026, 19:31 UTC

Alvotech SA shares are trading higher, reflecting market optimism after recent inflation data showed core CPI aligned with forecasts. No specific company news was identified.

11 de ago. de 2026, 19:26 UTC

Alvotech's Reykjavik facility receives Voluntary Action Indicated status from the FDA, allowing advancement of multiple Biologics License Applications. Shares are trading higher.

10 de ago. de 2026, 20:06 UTC

Alvotech SA will release its financial results for the first half of 2026 on August 19, after the U.S. market close. Shares are little changed.

6 de ago. de 2026, 20:06 UTC

Alvotech SA shares are higher today, trading above their 20-day moving average and near the upper end of their one-month range. No specific news was identified.

5 de ago. de 2026, 19:56 UTC

Alvotech SA shares are lower during Wednesday's session, continuing a decline since Tuesday's close amid broader market trends and falling oil prices.

4 de ago. de 2026, 19:52 UTC

Alvotech SA shares are higher today, supported by declining crude oil prices easing inflation concerns. The stock remains above its 20-day moving average.

3 de ago. de 2026, 19:51 UTC

Alvotech SA shares are lower today, reflecting a sharp decline despite a brief rebound earlier in the session. No specific news was identified for the drop.

31 de jul. de 2026, 21:02 UTC

Alvotech SA shares declined in after-market trading, reversing six days of gains. No specific news was identified to explain the price movement.

30 de jul. de 2026, 20:10 UTC

Alvotech SA shares are higher during Thursday's session, reflecting broader market movements amid mixed economic signals and maintaining a position above the 20-day moving average.

29 de jul. de 2026, 19:04 UTC

Alvotech SA's FDA inspection results in a Voluntary Action Indicated classification. Shares are trading higher as the company advances its biosimilar pipeline.

28 de jul. de 2026, 19:56 UTC

Alvotech SA shares are higher today, reaching a high of 6.17%. The stock remains below its 20-day moving average with no specific news identified.

27 de jul. de 2026, 19:31 UTC

Alvotech SA shares are higher today, rebounding from an earlier session low. This follows a positive trend since Friday's close amid declining oil prices.

24 de jul. de 2026, 19:51 UTC

Alvotech SA shares are lower today, continuing a trend of weakness amid broader market pressures and three consecutive lower daily closes.

22 de jul. de 2026, 18:31 UTC

Alvotech SA shares are lower, continuing a decline since Tuesday. Broader market sentiment is impacted by geopolitical tensions and rising crude oil prices.

21 de jul. de 2026, 19:16 UTC

Alvotech SA shares are higher during Tuesday's session amid a broader market recovery, driven by renewed interest in AI stocks and upcoming tech earnings.

20 de jul. de 2026, 19:31 UTC

Alvotech SA shares are lower today, with no specific news identified. Broader market weakness includes a decline in the US 10Y Treasury Bond index.